We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Cannabics

News List

Cannabics Pharmaceuticals and Purisys sign cannabinoid API supply agreement CPhIonline
November 08, 2021
Purisys has agreed to supply Cannabics Pharmaceuticals, a global developer of cancer-related cannabinoid-based medicine, with GMP-grade APIs required for the manufacturing of its colorectal cancer treatment drug candidate.
Cannabics Concludes Pre-Clinical Study on Human Biopsies americanpharmaceuticalreview
November 19, 2020
Cannabics Pharmaceuticals has completed a pre-clinical study using its proprietary and novel RCC-33 formulation on human biopsies, obtained under a Helsinki Committee approved protocol.
Cannabics Plans pre-IND Meeting Request for Colon Cancer Drug Candidate americanpharmaceuticalreview
October 28, 2020
Cannabics Pharmaceuticals has signed an agreement with a clinical quality and validation processes consultancy to oversee the preparation and submission of a Pre-IND Meeting request to the FDA on its anti-tumor Drug Candidate CANNABICS™ RCC-33 ...